Exact Mass: 538.4961

Exact Mass Matches: 538.4961

Found 176 metabolites which its exact mass value is equals to given mass value 538.4961, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Nb-Hexacosanoyltryptamine

N-[2-(1H-indol-3-yl)Ethyl]hexacosanimidate

C36H62N2O (538.4862)


Nb-Hexacosanoyltryptamine is found in alcoholic beverages. Nb-Hexacosanoyltryptamine is an alkaloid from seeds of Annona reticulata (custard apple) and Rollina mucosa (biriba). Alkaloid from seeds of Annona reticulata (custard apple) and Rollina mucosa (biriba). Nb-Hexacosanoyltryptamine is found in alcoholic beverages and fruits.

   

FAHFA(16:0/12-O-18:0)

12-[(1-oxohexadecyl)oxy]-octadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/12-O-18:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 12-hydroxyoctadecanoic acid. It is alternatively named 12-PAHSA since it is the 12-hydroxy isomer of the PAHSA (palmitic acid-hydroxystearic acid) family.

   

FAHFA(16:0/9-O-18:0)

9-​[(1-​oxohexadecyl)​oxy]​-octadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/9-O-18:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 9-hydroxyoctadecanoic acid. It is alternatively named 9-PAHSA since it is the 9-hydroxy isomer of the PAHSA (palmitic acid-hydroxystearic acid) family.↵↵↵

   

FAHFA(16:0/5-O-18:0)

5-[(1-oxohexadecyl)oxy]-octadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/5-O-18:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 5-hydroxyoctadecanoic acid. It is alternatively named 5-PAHSA since it is the 5-hydroxy isomer of the PAHSA (palmitic acid-hydroxystearic acid) family.

   

FAHFA(16:0/10-O-18:0)

10-[(1-oxohexadecyl)oxy]-octadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/10-O-18:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 10-hydroxyoctadecanoic acid. It is alternatively named 10-PAHSA since it is the 10-hydroxy isomer of the PAHSA (palmitic acid-hydroxystearic acid) family.

   

FAHFA(16:0/7-O-18:0)

7-[(1-oxohexadecyl)oxy]-octadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/7-O-18:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 7-hydroxyoctadecanoic acid. It is alternatively named 7-PAHSA since it is the 7-hydroxy isomer of the PAHSA (palmitic acid-hydroxystearic acid) family.

   

FAHFA(16:0/8-O-18:0)

8-[(1-oxohexadecyl)oxy]-octadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/8-O-18:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 8-hydroxyoctadecanoic acid. It is alternatively named 8-PAHSA since it is the 8-hydroxy isomer of the PAHSA (palmitic acid-hydroxystearic acid) family.

   

FAHFA(16:0/11-O-18:0)

11-[(1-oxohexadecyl)oxy]-octadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/11-O-18:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 11-hydroxyoctadecanoic acid. It is alternatively named 11-PAHSA since it is the 11-hydroxy isomer of the PAHSA (palmitic acid-hydroxystearic acid) family.

   

FAHFA(16:0/13-O-18:0)

13-[(1-oxohexadecyl)oxy]-octadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/13-O-18:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 13-hydroxyoctadecanoic acid. It is alternatively named 13-PAHSA since it is the 13-hydroxy isomer of the PAHSA (palmitic acid-hydroxystearic acid) family.

   

FAHFA(18:0/5-O-16:0)

5-[(1-oxooctadecyl)oxy]-hexadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(18:0/5-O-16:0), in particular, is formed from the condensation of the carboxy group of stearic acid with the hydroxy group of 5-hydroxyhexadecanoic acid. It is alternatively named 5-SAHPA since it is the 5-hydroxy isomer of the SAHPA (stearic acid-hydroxypalmitic acid) family.

   

FAHFA(18:0/7-O-16:0)

7-[(1-oxooctadecyl)oxy]-hexadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(18:0/7-O-16:0), in particular, is formed from the condensation of the carboxy group of stearic acid with the hydroxy group of 7-hydroxyhexadecanoic acid. It is alternatively named 7-SAHPA since it is the 7-hydroxy isomer of the SAHPA (stearic acid-hydroxypalmitic acid) family.

   

FAHFA(18:0/8-O-16:0)

8-[(1-oxooctadecyl)oxy]-hexadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(18:0/8-O-16:0), in particular, is formed from the condensation of the carboxy group of stearic acid with the hydroxy group of 8-hydroxyhexadecanoic acid. It is alternatively named 8-SAHPA since it is the 8-hydroxy isomer of the SAHPA (stearic acid-hydroxypalmitic acid) family.

   

FAHFA(18:0/9-O-16:0)

9-[(1-oxooctadecyl)oxy]-hexadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(18:0/9-O-16:0), in particular, is formed from the condensation of the carboxy group of stearic acid with the hydroxy group of 9-hydroxyhexadecanoic acid. It is alternatively named 9-SAHPA since it is the 9-hydroxy isomer of the SAHPA (stearic acid-hydroxypalmitic acid) family.

   

FAHFA(18:0/10-O-16:0)

10-[(1-oxooctadecyl)oxy]-hexadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(18:0/10-O-16:0), in particular, is formed from the condensation of the carboxy group of stearic acid with the hydroxy group of 10-hydroxyhexadecanoic acid. It is alternatively named 10-SAHPA since it is the 10-hydroxy isomer of the SAHPA (stearic acid-hydroxypalmitic acid) family.

   

FAHFA(18:0/11-O-16:0)

11-[(1-oxooctadecyl)oxy]-hexadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(18:0/11-O-16:0), in particular, is formed from the condensation of the carboxy group of stearic acid with the hydroxy group of 11-hydroxyhexadecanoic acid. It is alternatively named 11-SAHPA since it is the 11-hydroxy isomer of the SAHPA (stearic acid-hydroxypalmitic acid) family.

   

FAHFA(18:0/12-O-16:0)

12-[(1-oxooctadecyl)oxy]-hexadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(18:0/12-O-16:0), in particular, is formed from the condensation of the carboxy group of stearic acid with the hydroxy group of 12-hydroxyhexadecanoic acid. It is alternatively named 12-SAHPA since it is the 12-hydroxy isomer of the SAHPA (stearic acid-hydroxypalmitic acid) family.

   

FAHFA(18:0/13-O-16:0)

13-[(1-oxooctadecyl)oxy]-hexadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(18:0/13-O-16:0), in particular, is formed from the condensation of the carboxy group of stearic acid with the hydroxy group of 13-hydroxyhexadecanoic acid. It is alternatively named 13-SAHPA since it is the 13-hydroxy isomer of the SAHPA (stearic acid-hydroxypalmitic acid) family.

   

FAHFA(16:0/6-O-18:0)

6-[(1-oxohexadecyl)oxy]-octadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/6-O-18:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 6-hydroxyoctadecanoic acid. It is alternatively named 6-PAHSA since it is the 6-hydroxy isomer of the PAHSA (palmitic acid-hydroxystearic acid) family.

   

FAHFA(18:0/6-O-16:0)

6-[(1-oxooctadecyl)oxy]-hexadecanoic acid

C34H66O4 (538.4961)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(18:0/6-O-16:0), in particular, is formed from the condensation of the carboxy group of stearic acid with the hydroxy group of 6-hydroxyhexadecanoic acid. It is alternatively named 6-SAHPA since it is the 6-hydroxy isomer of the SAHPA (stearic acid-hydroxypalmitic acid) family.

   

15,16-dimethyltriacontanedioic acid dimethyl ester

15,16-dimethyltriacontanedioic acid dimethyl ester

C34H66O4 (538.4961)


   

dimethyl 14,15-dimethyltriacontanedioate

dimethyl 14,15-dimethyltriacontanedioate

C34H66O4 (538.4961)


   
   

5-PAHSA

5-hexadecanoyloxy-octadecanoic acid

C34H66O4 (538.4961)


A FAHFA obtained by formal condensation of the carboxy group of palmitic acid with the hydroxy group of 5-hydroxystearic acid.

   

12-PAHSA

12-[(1-oxohexadecyl)oxy]-octadecanoic acid

C34H66O4 (538.4961)


A FAHFA obtained by formal condensation of the carboxy group of palmitic acid with the hydroxy group of 12-hydroxystearic acid.

   

9-PAHSA

9-[(1-oxohexadecyl)oxy]-octadecanoic acid

C34H66O4 (538.4961)


A FAHFA (fatty acid ester of a hydroxy fatty acid) obtained by formal condensation of the carboxy group of palmitic acid with the hydroxy group of 9-hydroxyoctadecanoic acid (9-hydroxystearic acid).

   

N-Cerotoyltryptamine

N-[2-(1H-indol-3-yl)ethyl]hexacosanamide

C36H62N2O (538.4862)


   

7-PAHSA

7-hexadecanoyloxy-octadecanoic acid

C34H66O4 (538.4961)


A FAHFA obtained by formal condensation of the carboxy group of palmitic acid with the hydroxy group of 7-hydroxystearic acid.

   

8-PAHSA

8-hexadecanoyloxy-octadecanoic acid

C34H66O4 (538.4961)


A FAHFA obtained by formal condensation of the carboxy group of palmitic acid with the hydroxy group of 8-hydroxystearic acid.

   

10-PAHSA

10-hexadecanoyloxy-octadecanoic acid

C34H66O4 (538.4961)


   

11-PAHSA

11-hexadecanoyloxy-octadecanoic acid

C34H66O4 (538.4961)


A FAHFA obtained by formal condensation of the carboxy group of palmitic acid with the hydroxy group of 11-hydroxystearic acid.

   

13-PAHSA

13-hexadecanoyloxy-octadecanoic acid

C34H66O4 (538.4961)


A FAHFA obtained by formal condensation of the carboxy group of palmitic acid with the hydroxy group of 13-hydroxystearic acid.

   

5-SAHPA

5-octadecanoyloxy-hexadecanoic acid

C34H66O4 (538.4961)


   

7-SAHPA

7-octadecanoyloxy-hexadecanoic acid

C34H66O4 (538.4961)


   

8-SAHPA

8-octadecanoyloxy-hexadecanoic acid

C34H66O4 (538.4961)


   

9-SAHPA

9-octadecanoyloxy-hexadecanoic acid

C34H66O4 (538.4961)


   

10-SAHPA

10-octadecanoyloxy-hexadecanoic acid

C34H66O4 (538.4961)


   

11-SAHPA

11-octadecanoyloxy-hexadecanoic acid

C34H66O4 (538.4961)


   

12-SAHPA

12-octadecanoyloxy-hexadecanoic acid

C34H66O4 (538.4961)


   

13-SAHPA

13-octadecanoyloxy-hexadecanoic acid

C34H66O4 (538.4961)


   

FAHFA 34:0;O

15-PAHSA;15-palmitoyloxystearic Acid

C34H66O4 (538.4961)


   

1,2-Dipalmitoyl Ethylene Glycol

1,2-Dipalmitoyl Ethylene Glycol

C34H66O4 (538.4961)


   

3-Hexadecanoyloxyoctadecanoic acid

3-Hexadecanoyloxyoctadecanoic acid

C34H66O4 (538.4961)


   

14-Palmitoyloxystearic acid

14-Palmitoyloxystearic acid

C34H66O4 (538.4961)


   

15-Palmitoyloxystearic acid

15-Palmitoyloxystearic acid

C34H66O4 (538.4961)


   

4-Palmitoyloxystearic acid

4-Palmitoyloxystearic acid

C34H66O4 (538.4961)


   

[1-[(Z)-docos-13-enoxy]-3-hydroxypropan-2-yl] nonanoate

[1-[(Z)-docos-13-enoxy]-3-hydroxypropan-2-yl] nonanoate

C34H66O4 (538.4961)


   

[1-hydroxy-3-[(Z)-octacos-17-enoxy]propan-2-yl] propanoate

[1-hydroxy-3-[(Z)-octacos-17-enoxy]propan-2-yl] propanoate

C34H66O4 (538.4961)


   

[1-[(Z)-hexacos-15-enoxy]-3-hydroxypropan-2-yl] pentanoate

[1-[(Z)-hexacos-15-enoxy]-3-hydroxypropan-2-yl] pentanoate

C34H66O4 (538.4961)


   

(1-hydroxy-3-nonoxypropan-2-yl) (Z)-docos-13-enoate

(1-hydroxy-3-nonoxypropan-2-yl) (Z)-docos-13-enoate

C34H66O4 (538.4961)


   

[1-hydroxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] heptanoate

[1-hydroxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] heptanoate

C34H66O4 (538.4961)


   

(1-hydroxy-3-tetradecoxypropan-2-yl) (Z)-heptadec-9-enoate

(1-hydroxy-3-tetradecoxypropan-2-yl) (Z)-heptadec-9-enoate

C34H66O4 (538.4961)


   

(1-hydroxy-3-undecoxypropan-2-yl) (Z)-icos-11-enoate

(1-hydroxy-3-undecoxypropan-2-yl) (Z)-icos-11-enoate

C34H66O4 (538.4961)


   

(1-hexadecoxy-3-hydroxypropan-2-yl) (Z)-pentadec-9-enoate

(1-hexadecoxy-3-hydroxypropan-2-yl) (Z)-pentadec-9-enoate

C34H66O4 (538.4961)


   

(1-hydroxy-3-octadecoxypropan-2-yl) (Z)-tridec-9-enoate

(1-hydroxy-3-octadecoxypropan-2-yl) (Z)-tridec-9-enoate

C34H66O4 (538.4961)


   

(1-decoxy-3-hydroxypropan-2-yl) (Z)-henicos-11-enoate

(1-decoxy-3-hydroxypropan-2-yl) (Z)-henicos-11-enoate

C34H66O4 (538.4961)


   

[1-[(Z)-henicos-11-enoxy]-3-hydroxypropan-2-yl] decanoate

[1-[(Z)-henicos-11-enoxy]-3-hydroxypropan-2-yl] decanoate

C34H66O4 (538.4961)


   

[1-hydroxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] dodecanoate

[1-hydroxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] dodecanoate

C34H66O4 (538.4961)


   

[1-hydroxy-3-[(Z)-icos-11-enoxy]propan-2-yl] undecanoate

[1-hydroxy-3-[(Z)-icos-11-enoxy]propan-2-yl] undecanoate

C34H66O4 (538.4961)


   

(1-hydroxy-3-pentadecoxypropan-2-yl) (Z)-hexadec-9-enoate

(1-hydroxy-3-pentadecoxypropan-2-yl) (Z)-hexadec-9-enoate

C34H66O4 (538.4961)


   

(1-dodecoxy-3-hydroxypropan-2-yl) (Z)-nonadec-9-enoate

(1-dodecoxy-3-hydroxypropan-2-yl) (Z)-nonadec-9-enoate

C34H66O4 (538.4961)


   

(1-heptadecoxy-3-hydroxypropan-2-yl) (Z)-tetradec-9-enoate

(1-heptadecoxy-3-hydroxypropan-2-yl) (Z)-tetradec-9-enoate

C34H66O4 (538.4961)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] octadecanoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] octadecanoate

C34H66O4 (538.4961)


   

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] pentadecanoate

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] pentadecanoate

C34H66O4 (538.4961)


   

[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] tetradecanoate

[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] tetradecanoate

C34H66O4 (538.4961)


   

[1-hydroxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] tridecanoate

[1-hydroxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] tridecanoate

C34H66O4 (538.4961)


   

(1-hydroxy-3-tridecoxypropan-2-yl) (Z)-octadec-9-enoate

(1-hydroxy-3-tridecoxypropan-2-yl) (Z)-octadec-9-enoate

C34H66O4 (538.4961)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] heptadecanoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] heptadecanoate

C34H66O4 (538.4961)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] hexadecanoate

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] hexadecanoate

C34H66O4 (538.4961)


   
   

2-Palmitoyloxystearic acid

2-Palmitoyloxystearic acid

C34H66O4 (538.4961)


   
   
   

Fahfa 26:0/8:0

Fahfa 26:0/8:0

C34H66O4 (538.4961)


   

Fahfa 7:0/27:0

Fahfa 7:0/27:0

C34H66O4 (538.4961)


   

Fahfa 9:0/25:0

Fahfa 9:0/25:0

C34H66O4 (538.4961)


   

Fahfa 25:0/9:0

Fahfa 25:0/9:0

C34H66O4 (538.4961)


   

Fahfa 27:0/7:0

Fahfa 27:0/7:0

C34H66O4 (538.4961)


   

Fahfa 8:0/26:0

Fahfa 8:0/26:0

C34H66O4 (538.4961)


   

Fahfa 23:0/11:0

Fahfa 23:0/11:0

C34H66O4 (538.4961)


   

Fahfa 13:0/21:0

Fahfa 13:0/21:0

C34H66O4 (538.4961)


   

Fahfa 10:0/24:0

Fahfa 10:0/24:0

C34H66O4 (538.4961)


   

Fahfa 15:0/19:0

Fahfa 15:0/19:0

C34H66O4 (538.4961)


   

Fahfa 19:0/15:0

Fahfa 19:0/15:0

C34H66O4 (538.4961)


   

Fahfa 21:0/13:0

Fahfa 21:0/13:0

C34H66O4 (538.4961)


   

Fahfa 24:0/10:0

Fahfa 24:0/10:0

C34H66O4 (538.4961)


   

Fahfa 22:0/12:0

Fahfa 22:0/12:0

C34H66O4 (538.4961)


   

Fahfa 12:0/22:0

Fahfa 12:0/22:0

C34H66O4 (538.4961)


   

Fahfa 11:0/23:0

Fahfa 11:0/23:0

C34H66O4 (538.4961)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

16-Palmitoyloxystearic acid

16-Palmitoyloxystearic acid

C34H66O4 (538.4961)


   

17-Palmitoyloxystearic acid

17-Palmitoyloxystearic acid

C34H66O4 (538.4961)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-[2-(1H-indol-3-yl)ethyl]hexacosanamide

N-[2-(1H-indol-3-yl)ethyl]hexacosanamide

C36H62N2O (538.4862)


   

OAHFA(34:0)

OAHFA(16:0_18:0)

C34H66O4 (538.4961)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-Tryptamine 26:0

NA-Tryptamine 26:0

C36H62N2O (538.4862)


   

FAHFA 10:0/O-24:0

FAHFA 10:0/O-24:0

C34H66O4 (538.4961)


   

FAHFA 11:0/O-23:0

FAHFA 11:0/O-23:0

C34H66O4 (538.4961)


   

FAHFA 12:0/2O-22:0

FAHFA 12:0/2O-22:0

C34H66O4 (538.4961)


   

FAHFA 12:0/O-22:0

FAHFA 12:0/O-22:0

C34H66O4 (538.4961)


   

FAHFA 13:0/O-21:0

FAHFA 13:0/O-21:0

C34H66O4 (538.4961)


   

FAHFA 14:0/O-20:0

FAHFA 14:0/O-20:0

C34H66O4 (538.4961)


   

FAHFA 15:0/O-19:0

FAHFA 15:0/O-19:0

C34H66O4 (538.4961)


   

FAHFA 16:0/12O-18:0

FAHFA 16:0/12O-18:0

C34H66O4 (538.4961)


   

FAHFA 16:0/O-18:0

FAHFA 16:0/O-18:0

C34H66O4 (538.4961)


   

FAHFA 17:0/O-17:0

FAHFA 17:0/O-17:0

C34H66O4 (538.4961)


   

FAHFA 18:0/3O-16:0

FAHFA 18:0/3O-16:0

C34H66O4 (538.4961)


   

FAHFA 18:0/O-16:0

FAHFA 18:0/O-16:0

C34H66O4 (538.4961)


   

FAHFA 19:0/O-15:0

FAHFA 19:0/O-15:0

C34H66O4 (538.4961)


   

FAHFA 20:0/2O-14:0

FAHFA 20:0/2O-14:0

C34H66O4 (538.4961)


   

FAHFA 20:0/O-14:0

FAHFA 20:0/O-14:0

C34H66O4 (538.4961)


   

FAHFA 21:0/O-13:0

FAHFA 21:0/O-13:0

C34H66O4 (538.4961)


   

FAHFA 22:0/O-12:0

FAHFA 22:0/O-12:0

C34H66O4 (538.4961)


   

FAHFA 23:0/O-11:0

FAHFA 23:0/O-11:0

C34H66O4 (538.4961)


   

FAHFA 24:0/O-10:0

FAHFA 24:0/O-10:0

C34H66O4 (538.4961)


   

FAHFA 25:0/O-9:0

FAHFA 25:0/O-9:0

C34H66O4 (538.4961)


   

FAHFA 26:0/O-8:0

FAHFA 26:0/O-8:0

C34H66O4 (538.4961)


   

FAHFA 8:0/O-26:0

FAHFA 8:0/O-26:0

C34H66O4 (538.4961)


   

FAHFA 9:0/O-25:0

FAHFA 9:0/O-25:0

C34H66O4 (538.4961)


   

DG O-14:0_17:1

DG O-14:0_17:1

C34H66O4 (538.4961)


   

DG O-16:0_15:1

DG O-16:0_15:1

C34H66O4 (538.4961)


   

DG O-16:1_15:0

DG O-16:1_15:0

C34H66O4 (538.4961)


   

DG O-18:1_13:0

DG O-18:1_13:0

C34H66O4 (538.4961)


   

DG O-20:1_11:0

DG O-20:1_11:0

C34H66O4 (538.4961)


   
   

DG P-14:0_17:0

DG P-14:0_17:0

C34H66O4 (538.4961)


   

DG P-16:0_15:0

DG P-16:0_15:0

C34H66O4 (538.4961)


   

DG P-18:0_13:0

DG P-18:0_13:0

C34H66O4 (538.4961)


   

DG P-20:0_11:0

DG P-20:0_11:0

C34H66O4 (538.4961)


   
   

4,5-ditridecyloctanedioic acid

4,5-ditridecyloctanedioic acid

C34H66O4 (538.4961)


   

n-[2-(1h-indol-3-yl)ethyl]hexacosanimidic acid

n-[2-(1h-indol-3-yl)ethyl]hexacosanimidic acid

C36H62N2O (538.4862)